Literature DB >> 8449502

Refinement of the spinal muscular atrophy locus to the interval between D5S435 and MAP1B.

V M Soares1, L M Brzustowicz, P W Kleyn, J A Knowles, D A Palmer, S Asokan, G K Penchaszadeh, T L Munsat, T C Gilliam.   

Abstract

The childhood-onset SMA locus has been mapped to chromosome 5q13, in a region bounded by the proximal locus, D5S6, and the closely linked distal loci, D5S112 and MAP1B. We now describe a highly polymorphic, tightly linked microsatellite marker (D5S435) that is very likely the closest proximal marker to the SMA locus. Multipoint linkage analysis firmly establishes the following order of markers at 5q13: centromere-D5S76-D5S6-D5S435-MAP1B/D5S112- D5S39-telomere. The data indicate that SMA resides in an approximately 0.7-cM (range 0.1-2.1) region between D5S435 and MAP1B. This finding reduces by approximately fourfold the genetic region that most likely harbors the SMA locus and will facilitate the physical mapping and cloning of the disease gene region.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8449502     DOI: 10.1006/geno.1993.1069

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  19 in total

1.  Refinement of the spinal muscular atrophy locus by genetic and physical mapping.

Authors:  C H Wang; P W Kleyn; E Vitale; B M Ross; L Lien; J Xu; T A Carter; L M Brzustowicz; S Obici; S Selig
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

2.  SMN gene analysis of the spinal form of Charcot-Marie-Tooth disease.

Authors:  A Hanash; E Leguern; N Birouk; O Clermont; J Pouget; P Bouche; A Munnich; A Brice; J Melki
Journal:  J Med Genet       Date:  1997-06       Impact factor: 6.318

3.  Spinal muscular atrophy genetic testing experience at an academic medical center.

Authors:  Shuji Ogino; Debra G B Leonard; Hanna Rennert; Robert B Wilson
Journal:  J Mol Diagn       Date:  2002-02       Impact factor: 5.568

4.  Genomic rearrangements in childhood spinal muscular atrophy: linkage disequilibrium with a null allele.

Authors:  R J Daniels; L Campbell; N R Rodrigues; M J Francis; K E Morrison; M McLean; A MacKenzie; J Ignatius; V Dubowitz; K E Davies
Journal:  J Med Genet       Date:  1995-02       Impact factor: 6.318

5.  A sublocus of the multicopy microsatellite marker CMS1 maps proximal to spinal muscular atrophy (SMA) as shown by recombinant analysis.

Authors:  G van der Steege; J M Cobben; J Osinga; H Scheffer; G J van Ommen; C H Buys
Journal:  Hum Genet       Date:  1995-11       Impact factor: 4.132

6.  Linkage mapping of the spinal muscular atrophy gene.

Authors:  A H Burghes; S E Ingraham; Z Kóte-Jarai; S Rosenfeld; N Herta; N Nadkarni; C J DiDonato; J Carpten; O Hurko; J Florence
Journal:  Hum Genet       Date:  1994-03       Impact factor: 4.132

7.  Use of genetic and physical mapping to locate the spinal muscular atrophy locus between two new highly polymorphic DNA markers.

Authors:  O Clermont; P Burlet; L Burglen; S Lefebvre; F Pascal; J McPherson; J J Wasmuth; D Cohen; D Le Paslier; J Weissenbach
Journal:  Am J Hum Genet       Date:  1994-04       Impact factor: 11.025

8.  A recombination event occurring within two complex 5q13.1 microsatellite repeat polymorphisms suggests a telomeric mapping of spinal muscular atrophy.

Authors:  Z Yaraghi; M D McLean; N Roy; L Surh; J E Ikeda; R G Korneluk; A MacKenzie
Journal:  Hum Genet       Date:  1995-09       Impact factor: 4.132

9.  Lethal congenital contracture syndrome (LCCS), a fetal anterior horn cell disease, is not linked to the SMA 5q locus.

Authors:  K Vuopala; P Mäkelä-Bengs; A Suomalainen; R Herva; J Leisti; L Peltonen
Journal:  J Med Genet       Date:  1995-01       Impact factor: 6.318

10.  Complex repetitive arrangements of gene sequence in the candidate region of the spinal muscular atrophy gene in 5q13.

Authors:  A M Theodosiou; K E Morrison; A M Nesbit; R J Daniels; L Campbell; M J Francis; Z Christodoulou; K E Davies
Journal:  Am J Hum Genet       Date:  1994-12       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.